Marksans Pharma
MARKSANS.NS
#4665
Rank
$1.62 B
Marketcap
$3.59
Share price
-3.65%
Change (1 day)
88.00%
Change (1 year)

Earnings for Marksans Pharma (MARKSANS.NS)

Earnings in 2024 (TTM): $56.46 Million USD

According to Marksans Pharma 's latest financial reports the company's current earnings are $0.28 Billion USD. In 2023 the company made an earning of $52.34 Million USD, an increase over its 2022 earnings that were of $36.83 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Marksans Pharma from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $56.46 M7.86%
2023 $52.34 M42.13%
2022 $36.83 M-7.19%
2021 $39.68 M11.01%
2020 $35.75 M106.33%
2019 $17.32 M37.56%
2018 $12.59 M34.07%
2017 $9.39 M175.17%
2016 $3.41 M-84.8%
2015 $22.46 M-8.77%
2014 $24.62 M24.53%
2013 $19.77 M